background
banner

ARIXTRA 10mg/0.8ml Price

Active Substance: Fondaparinux sodium.

927
UAD , based on 7541 reviews.
View Drug details

Overview

Welcome to Dwaey, specifically on ARIXTRA 10mg/0.8ml page.
This medicine contains an important and useful components, as it consists of
Fondaparinux sodiumis available in the market in concentration

Name

Fondaparinux

Precaution

Patient w/ increased risk of haemorrhage (e.g. congenital or acquired bleeding disorders, history or active GI ulceration, intracranial haemorrhage, recent brain, spinal or ophth surgery); body wt <50 kg. Increased risk of spinal or epidural haematomas in patient undergoing neuraxial (spinal/epidural) anaesth or spinal puncture esp w/ post-op use of indwelling epidural catheters and concurrent use of medications affecting haemostasis. Moderate renal and severe hepatic impairment. Pregnancy and lactation. Monitoring Parameters Monitor CBC, platelet count, serum creatinine and stool occult blood regularly. Lactation: Unknown whether drug is excreted in milk; use with caution

Indication

Venous thromboembolic events, acute DVT, pulmonary embolism (PE), unstable angina or non-ST segment elevation MI

Contra indication

Hypersensitivity. Active clinically significant bleeding, acute bacterial endocarditis.

Side Effect

>10% Anemia (1-20%),Fever (4-14%),Nausea (3-11%) 1-10% Rash (7.5%),Dizziness (4%),Confusion (3%),Constipation (5-9%),Diarrhea (2-3%),Edema (9%),Headache (2-5%),Hypokalemia (1-4%),Hypotension (4%),Insomnia (4-5%),Purpura (4%),Thrombocytopenia (3%),Urinary retention (3%),Urinary tract infection (2-4%),Vomiting (1-6%)

Pregnancy Category ID

2

Mode of Action

Fondaparinux, a synthetic pentasaccharide, acts as a selective inhibitor of activated factor X. It works by binding selectively to ATIII, and potentiates the neutralisation of Factor Xa. This will interrupt the blood coagulation cascade and inhibit both thrombin formation and thrombus development. At the recommended dosage, fondaparinux does not affect fibrinolytic activity or platelet function. It cannot lyse established thrombi and does not affect clotting function tests (e.g. aPPT, INR).

Interaction

Increased risk of bleeding w/ (e.g. desirudin, fibrinolytic drugs, glycoprotein IIb/IIIa-receptor antagonists, heparin, heparinoids or LMWH).

Pregnancy Category Note

Information not available

Adult Dose

Child Dose

Renal Dose

Administration

banner

Contact Us / Report Error

Please contact us for any inquiries or report any errors.

Or U can Send Us Email: [email protected]